Almotriptan C₁₇H₂₅N₃O₂S

Therapeutic indications

Almotriptan is indicated for:

Migraine attacks

Population group: both men and women, only adults (18 years old or older)

Almotriptan is indicated for the acute treatment of the headache phase of migraine attacks with or without aura.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Almotriptan is contraindicated in the following cases:

Ischaemic heart disease, hypertension

at least one of
Ischaemic heart diseases
Hypertensive disorder, systemic arterial (disorder)

Lactation

Lactation

Ergotamine, ergotamine derivatives, 5-HT1B/1D agonists

at least one of
Ergot alkaloids
Ergot alkaloids
Ergot alkaloids
Ergot alkaloids
Selective serotonin (5HT1) agonists

Cerebrovascular accident (CVA) or transient ischaemic attack (TIA), peripheral vascular disease

at least one of
Cerebrovascular accident (disorder)
Transient ischemic attack (disorder)
Peripheral vascular disease (disorder)

Severe hepatic disease

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2015: ALMOGRAN Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈